CR2 and systemic lupus erythematosus: There is therefore ample evidence that CD21–/lowTbethi MBCs are expanded in SLE patients, and at frequencies that correlate with both disease activity and serum levels of typical lupus autoantibodies, e.g. anti-dsDNA, anti-Smith antigen and anti-RNP.